Uncategorized

National Cancer Advisory Board Accepts Blue Ribbon Panel’s Recommendations for Cancer Moonshot Initiative

Posted by  | Uncategorized

Today, the Blue Ribbon Panel of advisers for Vice President Joe Biden’s Cancer Moonshot Initiative presented a set of 10 recommendations for research opportunities worthy of investment. While these recommendations do not cover every corner of cancer research, they provide a framework for building on the progress we’ve made to help more scientists collaborate, make(...)

What are the different types of lung cancer? Is one more serious than the other?

Posted by  | Uncategorized

The two main categories of lung cancer are small-cell lung cancer, and non-small-cell lung cancer, says Russell K. Hales, M.D. “Non-small cell lung cancer is further divided into adenocarcinoma, and squamous cell carcinoma. “All lung cancer is aggressive, but all cancer in its early stages can be treated, and patients can have long term control(...)

I was diagnosed with restrictive lung disease. My mother and my cat died of lung cancer. I’m a non-smoker but worried about environmental issues. How likely is it that this will become lung cancer, and what would the treatment be?

Posted by  | Prevention/Screening, Uncategorized

“It's not just smoking that leads to lung cancer,” says Russell K. Hales, M.D. “ We know that environmental exposures and underlying lung disease can increase the likelihood of lung cancer. Unfortunately, in patients with restrictive lung disease, we don't have any information to show that screening those patients will increase the likelihood of finding(...)

Palliative medicine focus at #ASCO16 meeting

Palliative medicine focus at #ASCO16 meeting

Posted by  | treatment, Uncategorized

Tom Smith, M.D., wants cancer patients to live well. Fewer side effects, better quality of life, more joyful time with family…these are among the primary goals, he says, of palliative medicine. Researchers have studied the impact of palliative medicine programs on patients’ outcomes, and results show that patients benefit, says Smith. “A lot of aggressive(...)

Vice President Biden Speaks at Launch of Bloomberg~Kimmel Institute for Cancer Immunotherapy

Posted by  | Uncategorized

Vice President Joe Biden spoke to researchers, medical students, government leaders and others during the dedication of the new Bloomberg~Kimmel Institute for Cancer Immunotherapy. It was founded with gifts of $50 million each from Michael R. Bloomberg and Sidney Kimmel, and $25 million from more than a dozen additional supporters. Read the immunotherapy feature story(...)

Symposium Spotlight on Bladder Cancer

Symposium Spotlight on Bladder Cancer

Posted by  | Uncategorized

***This blog is the third in a three-part series on bladder cancer. Read parts one and two. The Johns Hopkins Greenberg Bladder Cancer Institute held its first public symposium with three leading bladder cancer experts providing novel new approaches to managing bladder cancer. “This institute, solely focused on bladder cancer, is the first one of(...)

Bivalacqua Directs Bladder Cancer Advocacy Network Meeting Panel

Posted by  | Uncategorized

***This blog is the second in a three-part series on bladder cancer. Read part one. Trinity Bivalacqua, M.D., Ph.D., director of urologic oncology in the James Buchanan Brady Urologic Institute and member of the Johns Hopkins Kimmel Cancer Center, co-chaired a panel discussion, “Data Sharing, Privacy Issues and Social Media,” at the Bladder Cancer Advocacy Network’s(...)

Bladder Cancer: No Longer Invisible

Posted by  | Uncategorized

***This blog is the first in a three-part series on bladder cancer. For too long, bladder cancer has been called the invisible cancer. But a recent convergence of strong philanthropic support and promising research findings are improving awareness and treatment of bladder cancer. Despite being the fifth most common cancer in the United States and(...)